Physician profile
Eric Thai
NPI 1588243067
$1,486.24
in general payments reported to CMS, 2019-2025
17 companies · $557 in 2025
The $557 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.75 · 2022: $17.38 · 2023: $420 · 2024: $473 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $463.72 | 2023-2025 | |
| Amgen INC. | $156.76 | 2023-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals Lp | $120.41 | 2023-2025 | Farxiga |
| Boston Scientific Corporation | $119.19 | 2023-2024 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $111.80 | 2023 | Xarelto |
| Merck Sharp & Dohme LLC | $96.94 | 2021-2025 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $88.54 | 2024-2025 | Evkeeza |
| E.R. Squibb & Sons, L.L.C. | $80.22 | 2022-2025 | Camzyos, Eliquis |
| Tarsus Pharmaceuticals, INC. | $59.16 | 2025 | Xdemvy |
| Recor Medical INC | $34.88 | 2025 | Paradise Ultrasound Renal Denervation System |
| Sanofi-Aventis U.S. LLC | $32.10 | 2024 | |
| Alnylam Pharmaceuticals INC. | $25.37 | 2025 | Amvuttra |
| Cvrx, INC. | $24.86 | 2025 | Barostim Neo System |
| Pfizer INC. | $20.99 | 2023 | |
| Altathera Pharmaceuticals LLC | $20.52 | 2025 | Sotalol Hydrochloride |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.83 | 2024 | Lifevest |
| Biotronik INC. | $14.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Thai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.